全球笔式注射器市场 – 行业趋势及 2030 年预测

笔式注射器市场分析和规模

注射笔是理想的选择，因为慢性病需要频繁用药。注射笔已取代其他注射药物输送方法成为标准。由于注射笔方便且患者无需医护人员协助即可直接注射，因此越来越受欢迎。

Data Bridge Market Research 分析称，2022 年笔式注射器市场规模为 35 亿美元，到 2030 年将飙升至 57.9248 亿美元，预计在预测期内复合年增长率为 6.5%。这表明了市场价值。由于对糖尿病检测的需求不断增长，糖尿病在治疗领域占据主导地位。

除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察之外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

笔式注射器市场范围和细分

市场定义

With the rise in Sthe healthcare sector, pen injectors have become the new standard for injectable drug-delivery systems. Their popularity has soared due to their simplicity, reliability, and ability to be administered directly by the patient without the aid of a physician. These devices require intensive, highly regulated testing to ensure that they work as intended every time. As their technology continues to develop and improve, the equipment to test them is becoming increasingly sophisticated through advanced automated capabilities and integrated sensors.

Global Pen Injectors Market Dynamics

Drivers

• Growing Prevalence of patients and promoting treatment to boost the market growth

Drugs are supposed to be administered into the body using injection pens as conveniently and painlessly as feasible. It is a small, portable device that can be held in the hand and used to give medications for treating many different conditions. It is estimated that over the forecasted period, the value of the injection pen market will increase due to the increased prevalence of chronic diseases, including osteoporosis and diabetes.

When applied on the skin, the pressure from the pen injector causes the actuation of a needle shield which engages the needle and causes the device to inject the drug. Pen injectors, on the other hand, typically serve patients with chronic diseases who require regular doses of medication to alleviate symptoms. These devices require the patient to activate a push-button, activating the needle into the targeted injection site.

• Research and development proficiencies

Rising expenditure for research and development proficiencies, especially in the developed and developing economies about medical devices and advanced products, will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments are also expected to drive the market growth rate.

When developing drug-delivery device systems, it is essential to identify equipment that can efficiently perform all required product testing while intelligently capturing and evaluating the test data per government regulations. The test system must also be flexible and modular enough that manufacturers can change and add functionality over time.

• Increasing government initiatives for improving healthcare

The healthcare sector is increasing rapidly, which s a significant impact on public health and economic activity. The increasing government initiatives for advanced systems enhance the demand for pen injectors. Pen Injectors are increasing in households, hospitals, and independent laboratories.

When developing and mass producing such devices, manufacturers usually perform a combination of testing to government-regulated standards and internal quality testing to ensure the efficacy of the device. Internal quality testing is often necessary because international standards committees cannot always amend testing standards as quickly as the device technology evolves.

Opportunities

• Upsurge in the public-private

Furthermore, an upsurge in the public-private funding for target research activities, rising demand for chronic diseases treatments using advanced drugs, and rising product innovations and development owing to technological advancements worldwide will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising internet penetration rate, rise in the elderly and obese population globally, and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

• High costs associated with research and development proficiencies

On the other hand, high costs associated with research and development proficiencies, limited infrastructural facilities, and a shortage of awareness in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

This pen injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pen injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In June 2023, Sanofi (France), the manufacturer of the Toujeo SoloStar Pens received approval from European Union to commercialize their product in the European region.
• In April 2020, the FDA approved Sanofi (Francenovel )'s Dupixent prefilled pen for use in managing atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. The pen can be used at home for administration.
• In January 2019, Merck KGaA released Pergoveris, an injectable gonadotropin pen for reproductive therapy in Germany.

Global Pen Injectors Market Scope

笔式注射器市场根据类型、剂量、疗法和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 一次性的
• 可重复使用的

剂量

• 固定的
• 多变的

治疗

• 糖尿病
• 过敏反应
• 生长激素治疗
• 生育能力
• 关节炎
• 骨质疏松症
• 癌症
• 自身免疫性疾病
• 其他的

最终用户

• 家庭护理
• 医院和诊所

全球笔式注射器市场区域分析/见解

对全球笔式注射器市场进行了分析，并按国家、类型、剂量、疗法和最终用户提供了市场规模洞察和趋势，如上所述。

笔式注射器市场报告涉及的国家包括美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。北美预计将在笔式注射器市场占据主导地位，因为该地区拥有强大的食品检测设施基础、主要参与者的强大影响力、慢性病病例的增加以及研究活动数量的增加。

由于政府加大力度提高认识、该地区研究活动不断增多、拥有大量未开发市场、人口众多以及对优质医疗服务的需求不断增长，预计亚太地区将在 2023 年至 2030 年的预测期内实现显著增长。

报告的国家部分还提供了影响单个市场影响因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。   

医疗保健基础设施增长安装基础和新技术渗透

笔式注射器市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、笔式注射器市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对笔式注射器市场的影响。数据适用于 2010-2020 年的历史时期。

竞争格局和笔式注射器市场份额分析

笔式注射器市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对笔式注射器市场的关注有关。

笔式注射器市场的一些主要参与者包括：

• 诺和诺德（丹麦）
• 美敦力（爱尔兰）
• BD（美国）
• 赛诺菲（法国）
• 礼来公司 (美国)
• 默克集团（德国）
• 阿斯利康（英国）
• F. Hoffmann-La Roche Ltd（瑞士）
• Owen Mumford Ltd（英国）
• Ypsomed AG（瑞士）
• Terumo Medical Corporation（日本）
• B. Braun（德国）
• 太阳制药工业有限公司 (印度)

SKU-28657